Average Co-Inventor Count = 2.85
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Guilford Pharmaceuticals, Inc. (16 from 98 patents)
2. Gpi Nil Holdings Inc. (16 from 66 patents)
3. Mgi Gp, Inc. (6 from 7 patents)
4. Eisai Inc. (3 from 33 patents)
5. Eisai Corporation of North America (2 from 4 patents)
6. Other (1 from 832,680 patents)
44 patents:
1. 8129382 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
2. 7915280 - Compounds and their uses
3. 7750008 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
4. RE41150 - Compounds and their use
5. 7601719 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
6. 7456178 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
7. 7307080 - Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
8. 7268138 - Compounds, methods and pharmaceutical compositions for inhibiting PARP
9. 7247641 - Compounds, derivatives, compositions, preparation and uses
10. 7235557 - Compounds and their uses
11. 7157452 - Substituted 4,9-dihydrocyclopenta{imn}phenanthridine-5-ones derivatives thereof and their uses
12. 6984639 - Heterocyclic ketone and thioester compounds and uses
13. 6887996 - Compounds and their use
14. 6723733 - Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses
15. 6716828 - Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage